Results 271 to 280 of about 114,562 (319)

Protein-Protein Interactions in Papillary and Nonpapillary Urothelial Carcinoma Architectures: Comparative Study. [PDF]

JMIR Bioinform Biotechnol
Chou C, Baykara Y, Hacking S, Amin A, Cheng L, Uzun A, Gamsiz Uzun ED.   +6 more
europepmc   +1 more source

Significance of monocyte-to-lymphocyte ratio as a prognostic factor in canine urothelial carcinoma: a retrospective study. [PDF]

J Vet Med Sci
Komori M, Ogawa M, Yonezawa T, Momoi Y, Maeda S.   +4 more
europepmc   +1 more source

Dysregulation of mRNA splicing in urothelial carcinoma: Clinical, diagnostic and therapeutic implications. [PDF]

Bladder Cancer
Columbres RCA, Apolo AB, Rouf Banday A.
europepmc   +1 more source

Bladder urothelial carcinoma

, 2013
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Molecular pathology of urothelial carcinoma

Human Pathology, 2021
The current personalized oncology era has witnessed significant efforts to integrate clinical, pathological, and molecular classifications. The growing need for molecular biomarkers to feed personalized oncology, together with the unprecedented wealth of knowledge on the molecular basis of bladder cancer, has led to a novel approach to this disease ...
Antonio Lopez-Beltran, Alessia Cimadamore, Rodolfo Montironi, Liang Cheng   +3 more
openaire   +3 more sources

Glycosaminoglycans in urothelial carcinomas

Urological Research, 1983
The glycosaminoglycan (GAG) content in human urothelial carcinomas was biochemically determined and compared to that of normal urothelium and bladder wall of the calf. The total GAG content was elevated in urothelial carcinomas, and the distribution pattern differed from that of normal urothelium and bladder wall.
H, Rübben, R, Friedrichs, H W, Stuhlsatz, W, Lutzeyer   +3 more
openaire   +2 more sources

Avelumab Maintenance for Urothelial Carcinoma

New England Journal of Medicine, 2020
To the Editor: Powles et al. (Sept. 24 issue)(1) report the practice-changing results of the JAVELIN Bladder 100 trial, which assessed the advantage of maintenance avelumab therapy plus best supportive care over best supportive care alone with respect to overall survival among patients with advanced urothelial carcinoma who had had a response to first ...
Mollica V., Rizzo A., Massari F.
openaire   +4 more sources

Urothelial Carcinoma

New England Journal of Medicine, 2018
Conan, So, M Minhaj, Siddiqui
  +6 more sources

Urothelial Carcinoma

Surgical Pathology Clinics, 2022
Manju Aron, Ming Zhou
openaire   +2 more sources